Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) Debt to Equity (2017 - 2025)

Bioceres Crop Solutions' Debt to Equity history spans 7 years, with the latest figure at $0.45 for Q2 2025.

  • For Q2 2025, Debt to Equity fell 20.55% year-over-year to $0.45; the TTM value through Jun 2025 reached $0.45, down 20.55%, while the annual FY2025 figure was $0.45, 20.55% down from the prior year.
  • Debt to Equity for Q2 2025 was $0.45 at Bioceres Crop Solutions, down from $0.57 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.85 in Q2 2021 and bottomed at -$0.07 in Q4 2021.
  • The 5-year median for Debt to Equity is $0.46 (2025), against an average of $0.43.
  • The largest annual shift saw Debt to Equity tumbled 50.77% in 2021 before it soared 74.31% in 2024.
  • A 5-year view of Debt to Equity shows it stood at -$0.07 in 2021, then skyrocketed by 746.34% to $0.47 in 2022, then plummeted by 30.5% to $0.33 in 2023, then skyrocketed by 74.31% to $0.57 in 2024, then decreased by 20.55% to $0.45 in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Debt to Equity are $0.45 (Q2 2025), $0.57 (Q2 2024), and $0.33 (Q2 2023).